Stock

© iStock / bernie_moto

LifeVantage hit with suits after delay of financials

By Hank Schultz

Multilevel marketing company LifeVantage, based in Sandy UT, has been hit with a slew of shareholder lawsuits after saying it had to delay the release of its financial information because of internal accounting flaws.

Neptune slapped with two more shareholders' rights lawsuits

Neptune slapped with two more shareholders' rights lawsuits

By Hank Schultz

Krill oil producer Neptune Technologies and Bioressources has been slapped with two additional class action shareholders’ rights lawsuits and another two law firms have announced investigations into whether the company has violated securities laws.

Neptune hit with shareholders' rights lawsuit

Neptune hit with shareholders' rights lawsuit

By Hank Schultz

Neptune Technologies and Bioressources has been hit with a shareholder rights lawsuit over the Nov. 8 explosion and fire that destroyed the company’s production facility and a resulting steep decline in the company’s share price.

LifeVantage recalls product over metal contamination

LifeVantage recalls product over metal contamination

By Hank Schultz

LifeVantage, manufactures of herbal supplement Protandim, recently announced a product recall that reportedly could end up costing the company as much as $7 million before recovery from suppliers.

Shareholder rights law firm investigates Neptune

Shareholder rights law firm investigates Neptune

Zeldes & Haeggquist, a San Diego based shareholders rights law firm, has announced an investigation into possible securities violations by Neptune Technologies & Bioressources following the destruction by fire of the company’s production facilities...

DuPont succeeds in Danisco bid

DuPont succeeds in Danisco bid

By Caroline Scott-Thomas

US chemical group DuPont has successfully completed its tender offer for Danisco, as 92.2 percent of outstanding shares in the Danish food ingredients firm were tendered by Friday’s deadline, DuPont said on Monday.

DSM reports successful tender offer for Martek

DSM reports successful tender offer for Martek

By Mike Stones

Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers